• Médication - slideshow

Dutasteride Advodart

Prostatic hyperplasia treatment


avodart dutasteride

Dutasteride (Avodart™) is part of a group of medicines referred to as 5-alpha reductase type I & II inhibitors. It prevents the 5-alpha reductase type I & II enzyme of converting testosterone into its active form within the organism, dihydrotestosterone or DHT. DHT plays an important role in hereditary baldness in men (androgenetic alopecia). The 5-alpha reductase type I & II enzyme is found in higher concentration at the hair follicles of men suffering from androgenetic alopecia.

Dutasteride (Avodart™) is developed in 0,5-mg/day doses by the pharmaceutical company "GlaxoSmithKline" and is FDA approved (U.S. Food and Drug Administration) for treating prostatic hyperplasia under the brand name Avodart™ (reference : 21-319/S-001). At present Dutasteride has not been approved for treating androgenetic alopecia.

The immediate side effects of Dustasteride are considerable and not well known on long-term scope.


If you wish , you can proceed with a face-to-face consultation ?
Other questions ?

Please contact us so we can help you as soon as possible.

Contact us

Logo BeClinic
Brussels esthetics

Copyright 2017 - Be Clinic  |  466 Brusselsesteenweg 3090 Overijse - Belgium  |  Website created by  Zzam.be

By pursuing your navigation on this website, you accept the use of cookies to purpose you a better navigation.